Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sq 26900
2. Sq 26991
3. Sq-26900
4. Sq-26991
5. Zofenil
6. Zofenopril
7. Zofenopril, Calcium Salt, (1(r*),2alpha,4alpha)-isomer
8. Zofil
1. 81938-43-4
2. Zofenopril Calcium Salt
3. Zoprace
4. Zofenopril Calcium [usan]
5. Sq 26991
6. Chebi:82600
7. 81938-43-4 (calcium)
8. 88zq329pu2
9. Zofenoprilcalcium
10. Sq-26991
11. Zofenopril Calcium (usan)
12. Calcium (2s,4s)-1-((s)-3-(benzoylthio)-2-methylpropanoyl)-4-(phenylthio)pyrrolidine-2-carboxylate
13. Unii-88zq329pu2
14. Bifril-d5
15. Zoprace (tn)
16. Ncgc00182038-01
17. Dsstox_cid_28551
18. Dsstox_rid_82823
19. Dsstox_gsid_48625
20. Schembl641349
21. Chembl2105776
22. Dtxsid1048625
23. Zofenopril Calcium [mart.]
24. Zofenopril Calcium [who-dd]
25. Tox21_112966
26. Mfcd08704648
27. Zofenopril Calcium Salt [mi]
28. Akos015840019
29. Akos015967030
30. Ac-4336
31. (4s)-n-((s)-3-mercapto-2-methylpropionyl)-4-(phenylthio)-l-proline Benzoate (ester), Calcium Salt
32. As-81847
33. So 26991
34. Cas-81938-43-4
35. Zofenopril Calcium, >98% (hplc), Powder
36. Z0041
37. D03767
38. A840224
39. Q-101025
40. Q27156118
41. (4s)-n-((s)-3-mercapto-2-methylpropionyl)-4-(phenylthio)-r-proline Benzoate (ester), Calcium Salt
42. [1(s),4(s)]-1-(3-mercapto-2-methyl-1-oxopropyl)-4-phenyl-thio-l-proline-s-benzoyl Ester Calcium Salt
43. Bis[1-[(s)-3-(benzoylthio)-2-methyl-1-oxopropyl]-4alpha-(phenylthio)-l-proline] Calcium Salt
44. Calcium (2r,4r)-1-[(2s)-3-benzoylsulfanyl-2-methyl-propanoyl]-4-phenylsulfanyl-pyrrolidine-2-carboxylate
45. Calcium Bis[(2s,4s)-1-[(2s)-3-(benzoylsulfanyl)-2-methylpropanoyl]-4-(phenylsulfanyl)pyrrolidine-2-carboxylate]
46. Calcium;(2s,4s)-1-[(2s)-3-benzoylsulfanyl-2-methylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylate
47. L-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, Calcium Salt, (1(r*),2alpha,4alpha)-
48. R-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, Calcium Salt, (1(r*),2.alpha.,4.alpha.)-
Molecular Weight | 897.2 g/mol |
---|---|
Molecular Formula | C44H44CaN2O8S4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 14 |
Exact Mass | 896.1606419 g/mol |
Monoisotopic Mass | 896.1606419 g/mol |
Topological Polar Surface Area | 256 Ų |
Heavy Atom Count | 59 |
Formal Charge | 0 |
Complexity | 582 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Zofenopril Calcium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zofenopril Calcium, including repackagers and relabelers. The FDA regulates Zofenopril Calcium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zofenopril Calcium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zofenopril Calcium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zofenopril Calcium supplier is an individual or a company that provides Zofenopril Calcium active pharmaceutical ingredient (API) or Zofenopril Calcium finished formulations upon request. The Zofenopril Calcium suppliers may include Zofenopril Calcium API manufacturers, exporters, distributors and traders.
click here to find a list of Zofenopril Calcium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zofenopril Calcium DMF (Drug Master File) is a document detailing the whole manufacturing process of Zofenopril Calcium active pharmaceutical ingredient (API) in detail. Different forms of Zofenopril Calcium DMFs exist exist since differing nations have different regulations, such as Zofenopril Calcium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zofenopril Calcium DMF submitted to regulatory agencies in the US is known as a USDMF. Zofenopril Calcium USDMF includes data on Zofenopril Calcium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zofenopril Calcium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zofenopril Calcium suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zofenopril Calcium Drug Master File in Korea (Zofenopril Calcium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zofenopril Calcium. The MFDS reviews the Zofenopril Calcium KDMF as part of the drug registration process and uses the information provided in the Zofenopril Calcium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zofenopril Calcium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zofenopril Calcium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zofenopril Calcium suppliers with KDMF on PharmaCompass.
A Zofenopril Calcium written confirmation (Zofenopril Calcium WC) is an official document issued by a regulatory agency to a Zofenopril Calcium manufacturer, verifying that the manufacturing facility of a Zofenopril Calcium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zofenopril Calcium APIs or Zofenopril Calcium finished pharmaceutical products to another nation, regulatory agencies frequently require a Zofenopril Calcium WC (written confirmation) as part of the regulatory process.
click here to find a list of Zofenopril Calcium suppliers with Written Confirmation (WC) on PharmaCompass.
Zofenopril Calcium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zofenopril Calcium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zofenopril Calcium GMP manufacturer or Zofenopril Calcium GMP API supplier for your needs.
A Zofenopril Calcium CoA (Certificate of Analysis) is a formal document that attests to Zofenopril Calcium's compliance with Zofenopril Calcium specifications and serves as a tool for batch-level quality control.
Zofenopril Calcium CoA mostly includes findings from lab analyses of a specific batch. For each Zofenopril Calcium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zofenopril Calcium may be tested according to a variety of international standards, such as European Pharmacopoeia (Zofenopril Calcium EP), Zofenopril Calcium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zofenopril Calcium USP).
LOOKING FOR A SUPPLIER?